These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 15480814)
1. Donepezil and vitamin E for preventing cognitive dysfunction in small cell lung cancer patients: preliminary results and suggestions for future study designs. Jatoi A; Kahanic SP; Frytak S; Schaefer P; Foote RL; Sloan J; Petersen RC Support Care Cancer; 2005 Jan; 13(1):66-9. PubMed ID: 15480814 [TBL] [Abstract][Full Text] [Related]
2. Vitamin E and donepezil for the treatment of mild cognitive impairment. Petersen RC; Thomas RG; Grundman M; Bennett D; Doody R; Ferris S; Galasko D; Jin S; Kaye J; Levey A; Pfeiffer E; Sano M; van Dyck CH; Thal LJ; N Engl J Med; 2005 Jun; 352(23):2379-88. PubMed ID: 15829527 [TBL] [Abstract][Full Text] [Related]
3. Donepezil versus vitamin E in Alzheimer's disease: Part 2: mild versus moderate-severe Alzheimer's disease. Onofrj M; Thomas A; Luciano AL; Iacono D; Di Rollo A; D'Andreamatteo G; Di Iorio A Clin Neuropharmacol; 2002; 25(4):207-15. PubMed ID: 12151908 [TBL] [Abstract][Full Text] [Related]
4. Vitamin E and donepezil for the treatment of mild cognitive impairment. Marder K Curr Neurol Neurosci Rep; 2005 Sep; 5(5):337-8. PubMed ID: 16131415 [No Abstract] [Full Text] [Related]
5. Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo/practice effects in a 12-week, randomized, double-blind, placebo-controlled trial. Keefe RS; Malhotra AK; Meltzer HY; Kane JM; Buchanan RW; Murthy A; Sovel M; Li C; Goldman R Neuropsychopharmacology; 2008 May; 33(6):1217-28. PubMed ID: 17625502 [TBL] [Abstract][Full Text] [Related]
6. Effects of donepezil adjunctive treatment to ziprasidone on cognitive deficits in schizophrenia: a double-blind, placebo-controlled study. Fagerlund B; Søholm B; Fink-Jensen A; Lublin H; Glenthøj BY Clin Neuropharmacol; 2007; 30(1):3-12. PubMed ID: 17272964 [TBL] [Abstract][Full Text] [Related]
7. A 12-week, double-blind, placebo-controlled trial of donepezil as an adjunct to haloperidol for treating cognitive impairments in patients with chronic schizophrenia. Lee BJ; Lee JG; Kim YH J Psychopharmacol; 2007 Jun; 21(4):421-7. PubMed ID: 17092979 [TBL] [Abstract][Full Text] [Related]
9. Mild cognitive impairment--no benefit from vitamin E, little from donepezil. Blacker D N Engl J Med; 2005 Jun; 352(23):2439-41. PubMed ID: 15829528 [No Abstract] [Full Text] [Related]
10. A randomized, double-blind, placebo-controlled trial of donepezil to improve memory in epilepsy. Hamberger MJ; Palmese CA; Scarmeas N; Weintraub D; Choi H; Hirsch LJ Epilepsia; 2007 Jul; 48(7):1283-91. PubMed ID: 17484756 [TBL] [Abstract][Full Text] [Related]
11. A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5 years following adjuvant chemotherapy. Lawrence JA; Griffin L; Balcueva EP; Groteluschen DL; Samuel TA; Lesser GJ; Naughton MJ; Case LD; Shaw EG; Rapp SR J Cancer Surviv; 2016 Feb; 10(1):176-84. PubMed ID: 26130292 [TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting. Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990 [TBL] [Abstract][Full Text] [Related]
13. A double-blind, placebo-controlled trial of donepezil for the treatment of menopause-related cognitive loss. Devi G; Massimi S; Schultz S; Khosrowshahi L; Laakso UK Gend Med; 2007 Dec; 4(4):352-8. PubMed ID: 18215726 [TBL] [Abstract][Full Text] [Related]